SS-31: A Research Overview of the Mitochondria-Targeted Tetrapeptide in 2026

A long-running problem in mitochondrial biochemistry is how to deliver a small molecule to one specific membrane inside the organelle rather than distributing it throughout the cell. Conventional small-molecule antioxidants partition broadly across cellular compartments, and their local concentration at the inner mitochondrial membrane, where the respiratory chain generates reactive oxygen species, is difficult to control or even to measure. Experiments built on those compounds therefore struggle to separate questions of delivery from questions of mechanism. SS-31 emerged from a different design approach: rather than a freely diffusing scavenger, a short peptide whose physicochemical properties direct it to one membrane and one phospholipid. That design is what makes it an informative tool in bioenergetics research.

For in-vitro laboratory research use only. Not for human consumption.

What SS-31 Is

SS-31 is a synthetic tetrapeptide belonging to the Szeto-Schiller (SS) class of aromatic-cationic peptides, named for the two researchers whose laboratories characterized the series. The molecule is small — four residues, a molecular weight near 640 g/mol — and carries a distinctive alternating pattern of aromatic and basic residues that gives the class its name and its behavior.

The sequence is D-Arg-Dmt-Lys-Phe-NH₂, where Dmt is 2',6'-dimethyltyrosine. Three structural features matter for how the peptide behaves in experimental systems:

• The D-arginine at position one. Using the D-enantiomer rather than the natural L-form makes the peptide resistant to aminopeptidase cleavage, which is the primary route of degradation for short linear peptides in biological matrices.
• The alternating aromatic-cationic motif. The peptide carries a net charge of +3 at physiological pH, distributed across residues that also present bulky aromatic faces. This combination is what allows it to partition into a phospholipid bilayer while remaining water-soluble.
• The C-terminal amide. Capping the carboxyl terminus removes a negative charge and blocks carboxypeptidase activity, further extending the peptide's half-life in solution.

In the published literature SS-31 also appears under the code name MTP-131, depending on which development program the paper is describing. Researchers searching the literature should query both terms, because the naming shifted over time and the same molecule appears under different labels in papers separated by only a few years.

The Defining Property: Membrane-Potential-Independent Uptake

Most mitochondria-targeted compounds work by exploiting the electrochemical gradient across the inner mitochondrial membrane. Triphenylphosphonium-conjugated molecules, the most widely known example, accumulate inside energized mitochondria because the matrix is negatively charged relative to the cytosol and the lipophilic cation is pulled across. This is elegant, but it has a serious limitation for research on depolarized mitochondria: as membrane potential collapses, the compound stops accumulating. The organelles with the lowest potential take up the least compound, which complicates any experiment in a depolarized preparation.

SS-31 does not depend on membrane potential. Studies using isolated mitochondria treated with uncouplers such as FCCP — which collapse the proton gradient entirely — still show peptide accumulation in the inner membrane. The mechanism appears to be direct physicochemical partitioning: the aromatic residues insert into the hydrophobic core of the bilayer while the cationic residues remain associated with the anionic phospholipid headgroups at the interface.

This property is the single most important thing to understand about SS-31 in an experimental context. It means the peptide can be studied in depolarized preparations where potential-dependent probes accumulate poorly, and it means concentration inside the organelle is not a simple function of respiratory state.

Cardiolipin: The Molecular Target

The inner mitochondrial membrane contains a phospholipid found essentially nowhere else in the eukaryotic cell: cardiolipin. Structurally, cardiolipin is a dimeric phospholipid — two phosphatidyl moieties linked by a glycerol bridge, producing a molecule with four acyl chains and two negative charges on a conical rather than cylindrical geometry.

That conical shape is functionally important. Lipids with this geometry favor regions of high negative curvature, which is exactly the topology of the cristae — the deep invaginations of the inner membrane where the respiratory complexes are concentrated. Cardiolipin is enriched at cristae, and a substantial body of structural biology shows that it is not a passive bystander. Cardiolipin molecules are resolved in the crystal structures of respiratory complexes III and IV, occupying defined binding pockets. It is required for the proper assembly of respiratory supercomplexes. And it anchors cytochrome c to the inner membrane surface, holding this soluble electron carrier in position between complex III and complex IV.

SS-31 associates selectively with cardiolipin. The interaction has been characterized by NMR, by isothermal titration calorimetry, and by studies in model membranes with defined lipid compositions. The peptide binds cardiolipin-containing bilayers with markedly higher affinity than bilayers composed of neutral phospholipids, and the binding does not simply neutralize charge — it changes the packing behavior of the lipid.

The Cytochrome c Peroxidase Problem

The most mechanistically detailed line of SS-31 research concerns cytochrome c. Under normal conditions, cytochrome c functions as a single-electron shuttle: it accepts an electron from complex III, diffuses along the membrane surface, and delivers it to complex IV. Its heme iron is coordinated by a methionine residue in a compact, closed conformation.

When cytochrome c binds cardiolipin in a particular orientation, that methionine coordination can be disrupted. The heme iron becomes partially exposed, and the protein acquires a secondary activity — peroxidase activity. Instead of transferring single electrons cleanly, it begins catalyzing peroxidation reactions on nearby lipids, including the cardiolipin it is bound to. The peroxidized cardiolipin loses its ability to anchor cytochrome c, releasing it from the membrane. This is a self-amplifying loop, and it appears in the biochemical literature as an early event in mitochondrial dysfunction cascades.

Birk and colleagues (2013) examined SS-31 in this system, studying the conformation of membrane-bound cytochrome c, its peroxidase activity, and the cytochrome c-cardiolipin association in the presence of the peptide. The mechanism proposed in that work is that SS-31, by occupying cardiolipin interaction sites, alters the specific lipid-protein contacts that trigger the conformational change.

The hypothesis under study is therefore a genuinely different mode of action from radical scavenging. Rather than reacting stoichiometrically with reactive oxygen species after they form, the peptide is proposed to act upstream, on the structural conditions that permit their generation.

Cristae Architecture and Supercomplex Assembly

A second research domain concerns the physical organization of the inner membrane. Electron microscopy and electron tomography studies in models of mitochondrial stress consistently show cristae disorganization — loss of the tight lamellar arrangement, widening of the intracristal space, fragmentation of the membrane network.

Cristae morphology has been examined after SS-31 exposure in several such models. The interpretation offered in the literature connects back to cardiolipin: because cardiolipin's conical geometry stabilizes negative curvature, and because SS-31 binding alters cardiolipin packing, the hypothesis is that the peptide influences the membrane curvature that defines cristae topology.

Downstream of architecture is supercomplex assembly. Respiratory complexes I, III, and IV are not randomly dispersed; they organize into higher-order assemblies — respirasomes — that are thought to improve electron transfer efficiency by reducing the diffusion distance between components. Cardiolipin is required for supercomplex formation. Studies have examined the assembly state of supercomplexes after SS-31 exposure, measured by blue-native PAGE and by activity-based assays.

The functional parameter measured in these systems is coupling efficiency — the ratio of ATP produced per oxygen consumed. Coupling efficiency is linked to electron leak: electrons that leave the chain prematurely reduce molecular oxygen to superoxide. This is the throughline that connects the structural questions to the redox questions: the hypothesis is that inner-membrane organization influences how tightly electron transfer is coupled, and therefore how much superoxide is generated as a byproduct. On this reading SS-31 is not an antioxidant in the conventional sense at all.

Published Research Model Systems

SS-31 has been examined in published in-vitro and animal research across several model systems. The descriptions below summarize which systems have been used and what they measure; they are not claims about any effect in people, and the compound supplied here is for in-vitro laboratory research only.

Isolated Mitochondria and Model Membranes

Cell-free systems are where the mechanistic work is most direct. Isolated mitochondria allow respiration, membrane potential, and hydrogen peroxide emission to be measured under defined substrate conditions, and liposomes of defined lipid composition allow the cardiolipin interaction to be studied without the complexity of a living cell. NMR, isothermal titration calorimetry, fluorescence-based binding assays, and model-membrane biophysics have all been applied in this setting. Because every component is defined, these systems are also where controls for the aromatic-cationic motif and for charge alone are easiest to construct.

Cultured Cell Models

Cultured cell lines allow cellular uptake and subcellular localization to be studied with fluorescently labeled analogs and imaging, and allow respirometry to be run on intact or permeabilized cells. Lines carrying defined mitochondrial genetic variants are particularly informative: because such lines have a fixed underlying lesion, they allow researchers to ask whether an agent acting on membrane organization behaves differently from a compound that replaces a missing catalytic function. Measurements across these systems vary with the specific variant, which is itself informative about mechanism.

Animal Tissue Preparations

Published animal research has examined SS-31 in tissues with high mitochondrial density, including heart, kidney, and retina, where respiratory-chain organization is readily measured. In these studies the readouts are largely the same bioenergetic and structural measurements described later in this article — respirometry, ATP production rate, hydrogen peroxide emission, and electron microscopy of cristae — applied to mitochondria or tissue sections taken from the animal. Tissue-to-tissue differences in cardiolipin acyl-chain composition and mitochondrial content mean that measurements do not transfer directly between these preparations.

Retinal and Neuronal Preparations

Neurons depend on continuous oxidative phosphorylation and have little capacity to store energy reserves. Retinal tissue is of particular methodological interest because the photoreceptor inner segment is densely packed with mitochondria and the tissue is optically accessible for structural imaging. Published work has used these preparations to examine mitochondrial ultrastructure and bioenergetic parameters in a tissue where both can be measured in the same sample.

Distinguishing SS-31 From Conventional Antioxidants

Researchers designing experiments with SS-31 should be clear about what distinguishes it from the antioxidant compounds it is sometimes grouped with:

The practical implication for experimental design is that appropriate controls differ. Comparing SS-31 to a general antioxidant such as N-acetylcysteine tests a different hypothesis than comparing it to another mitochondria-targeted compound, and comparing it to a cardiolipin-binding molecule without the aromatic-cationic motif tests something different again.

Analytical Verification: What a COA Should Show

SS-31 presents specific analytical challenges that a researcher should understand when evaluating a certificate of analysis.

Purity by reverse-phase HPLC. The COA should report the HPLC purity together with the chromatogram itself. For a short peptide like SS-31, the impurity profile is dominated by deletion sequences (a residue missing from the chain) and incomplete deprotection products. Both elute close to the target peak, so the chromatogram should show adequate resolution — a single dominant peak with a clean baseline return, not a broad envelope with unresolved shoulders.

Identity by mass spectrometry. The theoretical monoisotopic mass should be reported alongside the observed mass. This matters more than usual for SS-31 because of the D-arginine and the dimethyltyrosine: a synthesis error that substitutes tyrosine for 2',6'-dimethyltyrosine produces a molecule with a different mass; substituting L-arginine for D-arginine leaves the mass unchanged, and only chiral analysis would detect it, which is why sourcing from a manufacturer with documented amino acid provenance matters.

Laboratory and method details. The COA should name the testing laboratory and state the analytical methods used — column, gradient, detection wavelength, and ionization mode. Method details allow a reader to judge whether closely eluting species would have been resolved.

Water content and net peptide content. Lyophilized peptides retain residual water and counterion (typically trifluoroacetate or acetate). The gross vial weight is not the peptide weight. Research requiring accurate molar concentrations should account for net peptide content.

Handling and Storage

Lyophilized SS-31 should be stored at -20°C, protected from light and moisture. The lyophilized form is substantially more stable than any solution, and the material should be kept in that state until it is needed.

General laboratory handling considerations for aromatic-cationic peptides of this class:

• Allow vials to equilibrate to room temperature before opening. Cold glass condenses atmospheric moisture, and water is the primary enemy of a lyophilized peptide's shelf stability.
• Avoid repeated freezing and thawing of any prepared solution. Each freeze-thaw event promotes aggregation and hydrolysis.
• Use appropriately inert labware. Cationic peptides adsorb to some plastic surfaces, which can silently reduce effective concentration in dilute preparations.
• Protect from light. The dimethyltyrosine residue is a photosensitive aromatic system.

This site does not publish solution-preparation instructions, concentration guides, or usage instructions of any kind. Those decisions belong to the researcher working under an approved study plan in a properly equipped laboratory.

Experimental Readouts Used in SS-31 Studies

Because SS-31 is proposed to act on membrane organization rather than on a single enzyme, no one assay captures its activity. The published literature converges on a set of complementary readouts, and researchers designing new work generally combine several of them.

High-resolution respirometry. Oxygen consumption measured in permeabilized cells or isolated mitochondria, with sequential substrate-uncoupler-inhibitor titration, gives state 3 (ADP-stimulated) and state 4 (leak) respiration rates. The respiratory control ratio derived from these is the classic index of coupling. SS-31 studies report leak respiration and maximal capacity separately, which matters because the proposed mechanism concerns electron slip rather than added catalytic capacity.

ATP production rate. Measured either luminometrically or by ³¹P magnetic resonance spectroscopy in intact tissue. Pairing ATP production with oxygen consumption yields the P/O ratio, which is the most direct measure of coupling efficiency and the readout most frequently cited in SS-31 papers.

Mitochondrial hydrogen peroxide emission. Amplex Red-based fluorimetry on isolated mitochondria quantifies the rate of H₂O₂ release. This is the measurement that distinguishes "produces fewer oxidants" from "removes oxidants after production" — a scavenger added to the assay buffer would suppress the signal without changing the underlying generation rate, whereas an agent acting on the conditions of generation would change the underlying rate itself. Careful SS-31 experiments include controls that separate these possibilities.

Blue-native PAGE for supercomplex assembly. Solubilizing mitochondrial membranes with digitonin under gentle conditions preserves higher-order respiratory assemblies, which then resolve as discrete bands. In-gel activity staining confirms that the assemblies are catalytically competent, not just physically associated.

Electron microscopy and tomography. Cristae density, intracristal space width, and membrane continuity are measured directly. Tomography is preferred over conventional thin-section EM because the three-dimensional reconstruction avoids sectioning artifacts that can mimic cristae disorganization.

Cardiolipin quantification and oxidation state. Mass spectrometry-based lipidomics quantifies total cardiolipin, its acyl chain composition, and the abundance of oxidized species. Since peroxidized cardiolipin is the proposed intermediate in the cytochrome c cascade, this readout tests the mechanistic hypothesis directly rather than inferring it from downstream effects.

Cytochrome c conformational state. Absorbance spectroscopy in the Soret region, or peroxidase activity assays using a chromogenic substrate, report on whether the heme iron is in the closed methionine-coordinated state or the open peroxidase-competent state.

Common Pitfalls in SS-31 Experimental Design

Several recurring problems appear in work with this compound, and most of them trace back to treating it as if it were a conventional small-molecule antioxidant.

Assuming concentration in the buffer equals concentration in the membrane. SS-31 partitions into cardiolipin-containing bilayers, so its effective local concentration in the inner membrane can be orders of magnitude above the nominal concentration in the medium. Reporting only the buffer concentration makes cross-study comparison difficult and can produce apparently contradictory concentration-response relationships between systems with different mitochondrial content.

Using isolated mitochondria without accounting for cardiolipin loss during preparation. Standard differential centrifugation procedures can strip loosely associated lipids and damage outer membranes. Preparations with degraded cardiolipin will respond differently from intact organelles, and preparation quality should be verified before drawing conclusions about the peptide.

Inappropriate comparator compounds. Comparing SS-31 to a cytosolic antioxidant tests the delivery hypothesis, not the mechanism hypothesis. A well-designed study includes at least one other mitochondria-targeted agent so that "targeted delivery" and "cardiolipin-specific action" can be separated.

Ignoring the aromatic residue's photosensitivity. Dimethyltyrosine absorbs in the near-UV. Prolonged exposure of stock solutions to laboratory lighting, particularly in clear tubes, degrades the peptide. Amber vials and minimized bench time are standard practice.

Repeated freezing and thawing. Aromatic-cationic peptides aggregate readily. An aliquoting strategy set up when a stock solution is first prepared avoids the silent concentration losses that accumulate over repeated freeze-thaw events and that show up in the data as increasing variance across a study's timeline.

Adsorption losses in dilute preparations. At low nanomolar working concentrations, a meaningful fraction of a +3-charged peptide can adsorb to standard polypropylene surfaces. Low-binding labware, or carrier protein where the experiment tolerates it, prevents an effect that otherwise looks like inconsistent potency.

Reading the SS-31 Literature Critically

The SS-31 literature spans roughly two decades and includes work from cell-free systems, isolated organelles, cultured cells, and multiple animal models, published under several names and by several independent groups. A few habits help in evaluating it.

Check whether the system had a cardiolipin defect. The proposed mechanism predicts that measurable differences should be largest where cardiolipin-dependent processes are impaired and smallest in well-coupled mitochondria. A study reporting no difference in a well-coupled control system is not contradictory; it is consistent with the proposed mechanism.

Distinguish short exposure from prolonged exposure. Structural measurements in isolated systems are made over minutes to hours; changes in mitochondrial biogenesis or content require longer timescales and involve different signaling. Papers reporting changes in mitochondrial content after prolonged exposure are describing an adaptive cellular response, not the primary molecular interaction.

Watch for the naming problem. Because the same compound appears under more than one name, a literature search on a single term returns a biased slice of the field, and the slice tends to correlate with the era and the sponsor. Meta-analyses that miss this produce incomplete pictures.

Separate structural endpoints from functional endpoints. Cristae morphology and P/O ratio are related but distinct measurements. Papers that measure only one and infer the other are making a reasonable but unverified inference.

Note the model species and tissue. Mitochondrial composition, cardiolipin acyl chain profile, and supercomplex organization vary between species and between tissues within a species. A measurement made in mouse cardiac mitochondria does not transfer directly to a cultured human fibroblast line.

Where SS-31 Sits in the Research Landscape

The compound occupies a specific niche. It is not a broad signaling modulator like AMPK activators, and it is not a redox buffer like glutathione precursors. It is proposed to be a structural agent that acts on one phospholipid in one membrane. That narrowness is a feature for experimental design — it makes the mechanistic hypothesis testable in a way that broader-acting compounds do not permit.

For researchers comparing mitochondrial research tools, the useful contrast set includes MOTS-c (a mitochondrial-derived peptide that acts through AMPK and retrograde nuclear signaling rather than membrane structure) and NAD+ (a redox coenzyme and sirtuin substrate acting on metabolic flux). All three are studied in mitochondrial contexts, but they engage completely different mechanisms, and using them as if they were interchangeable produces uninterpretable data.

Why Synthesis Quality Matters More Than Usual Here

Most research peptides are built entirely from standard L-amino acids using well-optimized solid-phase Fmoc chemistry. SS-31 is not. Two of its four residues are non-standard, and each introduces a specific failure mode that a careless synthesis will produce and a superficial certificate of analysis will not catch.

D-arginine. Incorporating the D-enantiomer requires purchasing the D-form building block, which costs several times more than the L-form. A substitution — deliberate or accidental — produces a peptide with an identical molecular formula, identical mass, and nearly identical HPLC retention behavior under standard achiral conditions. Only chiral chromatography or amino acid analysis after hydrolysis will detect it. The functional consequence is significant: the L-form is a substrate for aminopeptidases, so the material degrades far faster in any biological matrix, and experiments that depend on stability over hours will produce data that do not reproduce.

2',6'-dimethyltyrosine. Dmt is a specialty residue and is meaningfully more expensive again. Substituting plain tyrosine produces a molecule 28 Da lighter, which mass spectrometry will detect immediately — provided MS data is actually acquired and the theoretical mass is reported alongside the observed. A certificate that reports only "identity confirmed" without the numbers gives the researcher nothing to check.

Coupling difficulty at the sterically hindered positions. The dimethylation on the tyrosine ring adds steric bulk that slows the coupling reaction at that position. Under compressed synthesis schedules, incomplete coupling produces deletion sequences — chains missing the Dmt residue entirely. These are shorter, lighter, and typically elute earlier on reverse-phase HPLC, but if the gradient is too steep they co-elute with the target and inflate the apparent purity number.

C-terminal amidation. The peptide terminates in an amide, not a free acid. Using the wrong resin, or incomplete cleavage chemistry, yields the free-acid form: one Dalton heavier, one additional negative charge, and a different interaction profile with the anionic cardiolipin headgroup that the whole mechanism depends on.

The practical conclusion is that a purity percentage in isolation is not sufficient documentation for this compound. The chromatogram shape, the numeric mass comparison, and the method details all carry information that the summary number does not. A supplier that publishes the full analytical package is making it possible for a researcher to catch these problems. A supplier that publishes only a percentage is asking the reader to take the figure on trust.

Sourcing Considerations

The quality problems that affect the research peptide market apply with particular force to SS-31, for a specific reason: the two non-standard residues. D-arginine and 2',6'-dimethyltyrosine are more expensive starting materials than standard L-amino acids, and both require careful coupling conditions. A supplier cutting cost on raw materials or on synthesis time will produce material that fails on chirality or on the dimethylation, and neither failure is visible in a purity number alone.

What to require:

• Independent third-party testing, not in-house data. A laboratory with no financial interest in the outcome of the analysis.
• Both HPLC and MS on the same sample. Purity without identity is meaningless; identity without purity is equally so.
• The actual chromatogram, not just a summary number. The shape of the trace carries information the percentage does not.
• Named laboratory and method details. The testing laboratory and the analytical methods should be stated on the document.
• Frozen storage before dispatch. Sustained heat accelerates degradation, so ask how recently stock was made and whether it is held frozen until it ships.

Excalibur Peptides supplies SS-31 as a lyophilized research material shipped from the United States, and a Certificate of Analysis is published for this product. It is available on the SS-31 product page and in the COA database, so the analytical data can be reviewed before purchase.

Regulatory Status

The SS-31 described in this article is a research reagent, not an FDA-approved drug product, and is not intended for human use. It is sold as a laboratory reagent for in-vitro research and identification purposes only, under a research-use-only designation that buyers certify at checkout. Nothing in this overview describes or implies any use in people or animals. Researchers should confirm any institutional requirements for the purchase, storage, and disposal of research chemicals before ordering.

Frequently Asked Questions

What is SS-31?

SS-31 is a synthetic aromatic-cationic tetrapeptide (D-Arg-Dmt-Lys-Phe-NH₂) that concentrates in the inner mitochondrial membrane and associates selectively with cardiolipin. It has been examined in published in-vitro and animal research on cristae architecture, electron transport coupling efficiency, and cytochrome c peroxidase activity. It is supplied strictly for in-vitro laboratory research and is not for human consumption.

How does SS-31 differ from other mitochondria-targeted compounds?

Most mitochondria-targeted compounds accumulate by exploiting the membrane potential, so uptake falls as mitochondria become dysfunctional. SS-31 partitions into the inner membrane independently of membrane potential and acts through cardiolipin association rather than radical scavenging.

What analytical documentation is relevant for SS-31?

Reverse-phase HPLC with the chromatogram shown, and mass spectrometry reporting the observed mass alongside the theoretical mass, both from a named laboratory. Because SS-31 contains D-arginine and 2',6'-dimethyltyrosine, the numeric mass comparison is especially informative. A Certificate of Analysis is published for the Excalibur Peptides SS-31 product.

How should SS-31 be stored?

Lyophilized SS-31 should be stored at -20°C, protected from light and moisture, and kept in the lyophilized state until required. Repeated freezing and thawing of prepared solutions should be avoided.

Is the SS-31 sold here approved for human use?

No. The SS-31 sold here is a research reagent, not an FDA-approved drug product. It is supplied strictly for in-vitro laboratory research and identification purposes and is not intended for human or veterinary administration or any clinical application.

View the SS-31 product page · Browse the research catalog · View the COA database

All compounds referenced in this article are sold for in-vitro laboratory research purposes only. They are not approved by the FDA for human or veterinary use and are not intended for human use, veterinary use, or consumption of any kind. Always consult applicable regulations regarding peptide research in your jurisdiction.

Last updated: October 2026